Stock traders buy large volume of call options on Livent (NYSE:LTHM)

Livent Co. (NYSE:LTHM – Get Rating) was the recipient of some unusual options trades on Thursday. Equity investors bought 9,324 call options on the company. This represents an increase of approximately 45% from the typical daily volume of 6,421 call options.

Livent Trading up 3.4%

LTHM stock traded at $1.14 at midday on Thursday, hitting $34.36. 69,835 shares of the company were traded, against an average volume of 3,758,458. The company has a fifty-day simple moving average of $26.24 and a 200-day simple moving average of $25.45. The company has a quick ratio of 1.55, a current ratio of 2.60 and a leverage ratio of 0.19. Livent has a 12-month low of $19.35 and a 12-month high of $34.61. The company has a market capitalization of $6.16 billion, a P/E ratio of 62.04 and a beta of 1.88.

Livent Inc (NYSE:LTHM – Get Rating) last released quarterly earnings data on Tuesday, August 2. The company reported EPS of $0.37 for the quarter, beating the consensus estimate of $0.30 by $0.07. Livent had a net margin of 18.36% and a return on equity of 14.62%. During the same period last year, the company made earnings per share of $0.04. On average, stock research analysts expect Livent to post 1.38 earnings per share for the current fiscal year.

Analyst upgrades and downgrades

A d x1esports

Get your in-game wallet today!

This games and media holding company brings a unique consolidation strategy and a diverse mix of experiences brought by its management team to a changing and highly fragmented space.

LTHM has been the subject of a number of recent research reports. TheStreet upgraded Livent from a “c+” rating to a “b-” rating in a Tuesday, August 9 research note. CICC Research began covering Livent in a research report on Monday, August 8. They issued an “outperform” rating and a price target of $27.30 on the stock. Deutsche Bank Aktiengesellschaft cut its price target on Livent shares from $29.00 to $24.00 and set a “hold” rating for the company in a Wednesday, July 6 report. Mizuho lowered its price target on Livent shares from $34.00 to $30.00 and set a “neutral” rating on the stock in a Thursday, August 4, report. Finally, Citigroup raised its price target on Livent shares to $27.00 in a Tuesday, August 9 report. One analyst rated the stock with a sell rating, four issued a hold rating and eight assigned the company a buy rating. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.39.

Institutional entries and exits

Institutional investors and hedge funds have recently increased or reduced their stake in the company. BlackRock Inc. increased its holdings in Livent by 3.2% in the first quarter. BlackRock Inc. now owns 25,674,467 shares of the company valued at $669,334,000 after purchasing an additional 797,187 shares last quarter. Vanguard Group Inc. increased its stake in Livent by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 17,627,545 shares of the company worth $459,549,000 after acquiring an additional 109,353 shares last quarter. Wellington Management Group LLP increased its position in Livent by 5.7% in the first quarter. Wellington Management Group LLP now owns 7,824,996 shares of the company valued at $203,997,000 after acquiring an additional 421,082 shares in the last quarter. State Street Corp increased its stake in Livent by 1.9% in the second quarter. State Street Corp now owns 5,289,249 shares of the company valued at $120,013,000 after acquiring 99,374 additional shares last quarter. Finally, Allianz Asset Management GmbH increased its holding in Livent shares by 35.7% during the first quarter. Allianz Asset Management GmbH now owns 2,799,333 shares of the company worth $72,979,000 after purchasing an additional 736,174 shares in the last quarter. Institutional investors and hedge funds own 87.57% of the company’s shares.

About Livent

(Get a rating)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and Asia- Peaceful. The company offers lithium compounds for use in applications requiring specific performance, including battery-grade lithium hydroxide for use in high-performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceuticals, as well as a range of specialty lithium compounds, including high-purity lithium metal, which is used in non-rechargeable batteries and materials production lightweight for aerospace applications.

Featured Articles

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Livent, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Livent wasn’t on the list.

Although Livent currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

Comments are closed.